GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Idorsia Ltd (OTCPK:IDRSF) » Definitions » Shares Buyback Ratio %

IDRSF (Idorsia) Shares Buyback Ratio % : -5.45 (As of Mar. 04, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Idorsia Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Idorsia's current shares buyback ratio was -5.45%.


Idorsia Shares Buyback Ratio % Historical Data

The historical data trend for Idorsia's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Idorsia Shares Buyback Ratio % Chart

Idorsia Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shares Buyback Ratio %
Get a 7-Day Free Trial -0.14 -25.15 -6.27 -0.39 -0.71

Idorsia Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.16 -0.14 -0.63 -0.05 -4.59

Idorsia Shares Buyback Ratio % Calculation

Idorsia's Shares Buyback Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Dec. 2022 ) - Shares Outstanding (EOP) (A: Dec. 2023 )) / Shares Outstanding (EOP) (A: Dec. 2022 )
=(177.559 - 178.827) / 177.559
=-0.71%

Idorsia's Shares Buyback Ratio for the quarter that ended in Sep. 2024 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Jun. 2024 ) - Shares Outstanding (EOP) (A: Sep. 2024 )) / Shares Outstanding (EOP) (A: Jun. 2024 )
=(180.040 - 188.307) / 180.040
=-4.59%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Idorsia Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Idorsia's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Idorsia Business Description

Traded in Other Exchanges
Address
Hegenheimermattweg 91, Allschwil, CHE, 4123
Idorsia Ltd is a biopharmaceutical company engaged in discovering, developing, and commercializing of medicines for unmet medical needs. It is a biotech hub of Europe specialized in the discovery and development of small molecules, to provide innovative therapeutic options. The company focuses on multiple therapeutic areas which include the central nervous system, cardiovascular disorders, immunological disorders, and orphan diseases. Idorsia's development compounds target a number of different diseases such as Resistant Hypertension, lupus, insomnia, Cerebral vasospasm, and Fabry disease. Geographically, it derives revenue from Switzerland.

Idorsia Headlines

From GuruFocus

Full Year 2019 Idorsia Ltd Earnings Call Transcript

By GuruFocus Research 02-13-2024

Idorsia Ltd to Discuss the TRYVIO FDA Approval Transcript

By GuruFocus Research 03-26-2024

Half Year 2021 Idorsia Ltd Earnings Call Transcript

By GuruFocus Research 02-13-2024

Half Year 2020 Idorsia Ltd Earnings Call Transcript

By GuruFocus Research 02-13-2024

Idorsia Ltd at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 02-13-2024

Half Year 2019 Idorsia Ltd Earnings Call Transcript

By GuruFocus Research 02-13-2024